In the last 10 years local applications containing neomycin for the skin have been widely prescribed, and it has become evident that sensitisation is fairly common. More recently, framycetin (generally thought to be identical with neomycin B1) has also been widely used, and many patients sensitive to it are cross-sensitive to neomycin.2 The therapeutic uses of these drugs therefore need reassessment.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.